Michael Böhm

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure

Empagliflozin in Heart Failure with a Preserved Ejection Fraction

ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008

Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study

Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

Circulating Endothelial Progenitor Cells and Cardiovascular Outcomes